A Repeated-Dose Evaluation of Use of a Pain Relieving Drug and Safety of OROS Hydromorphone HCI in Patients With Chronic Cancer Pain
NCT00411034
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
463
Enrollment
INDUSTRY
Sponsor class
Conditions
Analgesics, Opioid
Pain
Interventions
DRUG:
OROS Hydromorphone HCI
Sponsor
Alza Corporation, DE, USA